Price $5.26 |
Market Cap
40.4M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
14.8
|
P/B
-
|
P/S
1.29
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
8.7K
|
FCF
-0.3
|
|
Op. Margin
13.70%
|
Net Margin
8.80%
|
ROE
-
|
ROI
47.60%
|
|
ROA
4.30%
|
EPS Growth
17.80%
|
Current Ratio
0.5
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Wave Life Sciences Ltd (WVE) | $4.26 | - | - | 409.2M | Strong Buy |
| LAVA Therapeutics NV (LVTX) | $2.24 | - | - | 49.9M | Strong Buy |
| Jazz Pharmaceuticals PLC (JAZZ) | $128.52 | - | - | 8.26B | Strong Buy |
| Star Equity Holdings Inc (STRR) | $1.09 | - | - | 16M | Strong Buy |
| Interpace Biosciences Inc (IDXG) | $1.29 | - | - | 11.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
